US FDA Mulls Granting Regulated Industry Flexibility To Respond To Misinformation
Executive Summary
The rapid pace with which inaccurate information can spread on social media may necessitate loosening some of FDA’s regulations on sponsors to let them respond, Commissioner Robert Califf said at the J.P. Morgan Healthcare Conference. Califf also worried about how legitimate debate can undermine public confidence in FDA.
You may also be interested in...
Hard Truths About Mistruths: US FDA’s Califf Switching Gears On Misinformation Fight
Fighting misinformation likely will not be successful, the FDA commissioner concedes, but stakeholders should join the campaign to increase the dissemination of truthful information.
Hard Truths About Mistruths: US FDA’s Califf Switching Gears On Misinformation Fight
Fighting misinformation likely will not be successful, the FDA commissioner conceded, but stakeholders should join the campaign to increase the dissemination of truthful information.
Hard Truths About Mistruths: US FDA’s Califf Switching Gears On Misinformation Fight
Fighting misinformation likely will not be successful, the FDA commissioner concedes, but stakeholders should join the campaign to increase the dissemination of truthful information.